Kabra Drugs Ltd () News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{ "main_header": { "sid": 271637, "name": "Kabra Drugs", "stock_name": "Kabra Drugs", "full_name": "Kabra Drugs Ltd", "name_url": "stocks-analysis/kabra-drugs", "exchange": 0, "exchangecode": "", "primexch": 0, "country_id": 34, "currency": "INR", "cmp": "25.02", "chg": 1.34, "chgp": "5.66%", "dir": 1, "prev_price": "23.68", "mcapval": "58.00 Cr", "mcap": "Micro Cap", "scripcode": 524322, "symbol": "", "ind_name": "Pharmaceuticals & Biotechnology", "ind_code": 4, "sector_id": 65, "indexname": "India SENSEX", "isin": "INE323K01017", "curr_date": "Aug 12, 03:30 PM", "curr_time": "20:42 PM", "last_traded_at": "Aug 12, 03:30 PM IST", "bse_nse_vol": "2.2 lacs", "exc_status": "Active", "traded_date": "Aug 12, 2026", "traded_date_str": "2026 08 12", "score": "", "scoreText": "", "Live": 0, "market_time": 0, "is_blur": 1, "is_blur_class": "blur-registerF-score-header", "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/kabra-drugs-271637-0&utm_source=Spage_Header_Score", "mojoone": { "ismore": 0 } }, "news": { "results": [ { "title": "When is the next results date for Kabra Drugs Ltd?", "link": "https://www.marketsmojo.com/news/result-analysis/when-is-the-next-results-date-for-kabra-drugs-ltd-4140724", "imagepath": "", "date": "2026-08-06 23:21:01", "description": "Kabra Drugs Ltd will declare its results on 12 August 2026...." }, { "title": "Kabra Drugs Ltd is Rated Sell by MarketsMOJO", "link": "https://www.marketsmojo.com/news/stock-recommendation/kabra-drugs-ltd-is-rated-sell-by-marketsmojo-4135160", "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/KabraDrugsLtd_mojoScore_4135160.png", "date": "2026-08-04 10:10:04", "description": "Kabra Drugs Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 22 June 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 04 August 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook." }, { "title": "Kabra Drugs Ltd is Rated Sell", "link": "https://www.marketsmojo.com/news/stock-recommendation/kabra-drugs-ltd-is-rated-sell-4115135", "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/KabraDrugsLtd_mojoScore_4115135.png", "date": "2026-07-22 10:10:32", "description": "Kabra Drugs Ltd is rated Sell by MarketsMOJO, with this rating last updated on 22 June 2026. However, all fundamentals, returns, and financial metrics discussed here reflect the company’s current position as of 22 July 2026, providing investors with the latest insights into the stock’s performance and outlook." }, { "title": "Kabra Drugs Ltd is Rated Sell by MarketsMOJO", "link": "https://www.marketsmojo.com/news/stock-recommendation/kabra-drugs-ltd-is-rated-sell-by-marketsmojo-4093531", "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/KabraDrugsLtd_mojoScore_4093531.png", "date": "2026-07-08 10:10:04", "description": "Kabra Drugs Ltd is rated Sell by MarketsMOJO, with this rating last updated on 22 June 2026. While the rating change occurred on that date, the analysis and financial metrics discussed here reflect the company’s current position as of 08 July 2026, providing investors with the most up-to-date perspective on the stock’s fundamentals, valuation, financial trend, and technical outlook." }, { "title": "Kabra Drugs Ltd Downgraded to Sell Amid Mixed Financials and Bearish Technicals", "link": "https://www.marketsmojo.com/news/stock-recommendation/kabra-drugs-ltd-downgraded-to-sell-amid-mixed-financials-and-bearish-technicals-4068381", "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/KabraDrugsLtd_mojoScore_4068381.png", "date": "2026-06-23 08:32:04", "description": "Kabra Drugs Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Hold to Sell as of 22 June 2026. This shift reflects a complex interplay of deteriorating technical indicators, valuation concerns, and mixed financial trends despite recent positive quarterly results." }, { "title": "Kabra Drugs Gains 1.06%: 2 Key Technical Signals Shape Weekly Trend", "link": "https://www.marketsmojo.com/news/stocks-in-action/kabra-drugs-gains-106-2-key-technical-signals-shape-weekly-trend-4066231", "imagepath": "", "date": "2026-06-21 11:00:52", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>15 Jun:</strong> Stock surges 13.50% to Rs.26.82 on upgrade to Hold</p>\n <p><strong>16 Jun:</strong> MarketsMOJO upgrades Kabra Drugs Ltd to Hold rating</p>\n <p><strong>17 Jun:</strong> Death Cross forms signalling potential bearish trend</p>\n <p><strong>19 Jun:</strong> Week closes at Rs.23.88, down 3.20% on final day</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.23.63</div></div>\n <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">Rs.23.88<..." }, { "title": "Kabra Drugs Ltd Forms Death Cross Signalling Potential Bearish Trend", "link": "https://www.marketsmojo.com/news/stocks-in-action/kabra-drugs-ltd-forms-death-cross-signalling-potential-bearish-trend-4059719", "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/KabraDrugsLtd_dealthcross_4059719.png", "date": "2026-06-17 18:00:17", "description": "Kabra Drugs Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has recently formed a Death Cross, a technical pattern where the 50-day moving average crosses below the 200-day moving average. This development signals a potential shift towards a bearish trend, raising concerns about the stock’s medium to long-term momentum and investor sentiment." }, { "title": "Kabra Drugs Ltd Upgraded to Hold by MarketsMOJO on Improved Technicals and Financials", "link": "https://www.marketsmojo.com/news/stock-recommendation/kabra-drugs-ltd-upgraded-to-hold-by-marketsmojo-on-improved-technicals-and-financials-4055384", "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/KabraDrugsLtd_mojoScore_4055384.png", "date": "2026-06-16 08:32:56", "description": "Kabra Drugs Ltd has seen its investment rating upgraded from Sell to Hold as of 15 June 2026, reflecting a notable improvement in its technical indicators and financial results. The pharmaceutical micro-cap’s Mojo Score rose to 58.0, signalling a more balanced outlook amid recent positive trends in sales growth, profitability, and market momentum." }, { "title": "Kabra Drugs Ltd is Rated Sell by MarketsMOJO", "link": "https://www.marketsmojo.com/news/stock-recommendation/kabra-drugs-ltd-is-rated-sell-by-marketsmojo-4035838", "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/KabraDrugsLtd_mojoScore_4035838.png", "date": "2026-06-04 10:10:48", "description": "Kabra Drugs Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 01 June 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 04 June 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trend, and technical outlook." } ], "total": 63, "sid": "271637", "stock_news_url": "https://www.marketsmojo.com/news/kabra-drugs-271637" }, "announcements": [ { "caption": "Board Meeting Intimation for Intimation Of Board Meeting To Be Held On 12-August-2026", "datetime": "05-Aug-2026", "details": "Kabra Drugs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2026 inter alia to consider and approve Board Meeting to be held on 12-August-2026", "source": "BSE" }, { "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018", "datetime": "09-Jul-2026", "details": "Certificate pursuant to Regulations 74 (5) of SEBI regulation 2018", "source": "BSE" }, { "caption": "Announcement under Regulation 30 (LODR)-Change of Company Name", "datetime": "07-Jul-2026", "details": "Fresh Certificate of Incorporation pursuant to Change of Name.", "source": "BSE" } ], "corporate_actions": [ { "img": "board-meeting.svg", "title": "BOARD MEETING", "msg": "", "data": [ { "title": "BOARD MEETING", "txt": "(12 Aug 2026)" } ] }, { "img": "dividend.svg", "title": "DIVIDEND", "msg": "No <strong>Dividend</strong> history available", "data": [] }, { "img": "splits.svg", "title": "SPLITS", "msg": "No <strong>Splits</strong> history available", "data": [] }, { "img": "bonus.svg", "title": "BONUS", "msg": "No <strong>Bonus</strong> history available", "data": [] }, { "img": "rights-issues.svg", "title": "RIGHTS", "msg": "No <strong>Rights</strong> history available", "data": [] } ] }

Key Events This Week

15 Jun: Stock surges 13.50% to Rs.26.82 on upgrade to Hold

16 Jun: MarketsMOJO upgrades Kabra Drugs Ltd to Hold rating

17 Jun: Death Cross forms signalling potential bearish trend

19 Jun: Week closes at Rs.23.88, down 3.20% on final day

Read full news article

Kabra Drugs Ltd Forms Death Cross Signalling Potential Bearish Trend

2026-06-17 18:00:17

Kabra Drugs Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has recently formed a Death Cross, a technical pattern where the 50-day moving average crosses below the 200-day moving average. This development signals a potential shift towards a bearish trend, raising concerns about the stock’s medium to long-term momentum and investor sentiment.

Read full news article

Kabra Drugs Ltd Upgraded to Hold by MarketsMOJO on Improved Technicals and Financials

2026-06-16 08:32:56

Kabra Drugs Ltd has seen its investment rating upgraded from Sell to Hold as of 15 June 2026, reflecting a notable improvement in its technical indicators and financial results. The pharmaceutical micro-cap’s Mojo Score rose to 58.0, signalling a more balanced outlook amid recent positive trends in sales growth, profitability, and market momentum.

Read full news article

Kabra Drugs Ltd is Rated Sell by MarketsMOJO

2026-06-04 10:10:48

Kabra Drugs Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 01 June 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 04 June 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trend, and technical outlook.

Read full news article